OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Intensity of Local Skin Reactions During 5-Fluorouracil Treatment Related to the Number of Actinic Keratosis Lesions: A Post Hoc, Exploratory Analysis
Eggert Stockfleth, Nathalie Bégeault, Alain Delarue
Dermatology and Therapy (2021) Vol. 12, Iss. 2, pp. 467-479
Open Access | Times Cited: 16
Eggert Stockfleth, Nathalie Bégeault, Alain Delarue
Dermatology and Therapy (2021) Vol. 12, Iss. 2, pp. 467-479
Open Access | Times Cited: 16
Showing 16 citing articles:
European consensus‐based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV ‐induced dysplasia and field cancerization on behalf of European Association of Dermato‐Oncology, European Dermatology Forum, European Academy of Dermatology and Venereology and Union of Medical Specialists (Union Européenne des Médecins Spécialistes)
Lidija Kandolf, Ketty Peris, Josep Malvehy, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 6, pp. 1024-1047
Closed Access | Times Cited: 21
Lidija Kandolf, Ketty Peris, Josep Malvehy, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 6, pp. 1024-1047
Closed Access | Times Cited: 21
Field Cancerization Therapies for the Management of Actinic Keratosis: An Updated Review
Ishita Aggarwal, Carolina Puyana, Neha Chandan, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 3, pp. 391-405
Closed Access | Times Cited: 11
Ishita Aggarwal, Carolina Puyana, Neha Chandan, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 3, pp. 391-405
Closed Access | Times Cited: 11
Pharmacological Agents Used in the Prevention and Treatment of Actinic Keratosis: A Review
Domenico Arcuri, Brandon Ramchatesingh, François Lagacé, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4989-4989
Open Access | Times Cited: 21
Domenico Arcuri, Brandon Ramchatesingh, François Lagacé, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4989-4989
Open Access | Times Cited: 21
Actinic keratosis: Current challenges and unanswered questions
Josep Malvehy, Alexander J. Stratigos, M. Bagot, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. S5, pp. 3-11
Open Access | Times Cited: 5
Josep Malvehy, Alexander J. Stratigos, M. Bagot, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. S5, pp. 3-11
Open Access | Times Cited: 5
Targeting Staphylococcus aureus dominated skin dysbiosis in actinic keratosis to prevent the onset of cutaneous squamous cell carcinoma: Outlook for future therapies?
Jacoba I. Bromfield, Philip Hugenholtz, Ian H. Frazer, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 12
Jacoba I. Bromfield, Philip Hugenholtz, Ian H. Frazer, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 12
Association Between Local Skin Reactions and Efficacy with 5-Fluorouracil 4% Cream in Actinic Keratosis: A Post-Hoc Analysis of Two Randomised Clinical Trials
Markus V. Heppt, Kilian Trin, Anne-Cécile Mille, et al.
Dermatology and Therapy (2025)
Open Access
Markus V. Heppt, Kilian Trin, Anne-Cécile Mille, et al.
Dermatology and Therapy (2025)
Open Access
Reshaping treatment paradigm in actinic keratosis by using a modified Delphi questionnaire
Thomas Dirschka, Marco Ardigò, Maria Concetta Fargnoli, et al.
Journal of Dermatological Treatment (2025) Vol. 36, Iss. 1
Open Access
Thomas Dirschka, Marco Ardigò, Maria Concetta Fargnoli, et al.
Journal of Dermatological Treatment (2025) Vol. 36, Iss. 1
Open Access
Management of Local Skin Reactions Caused by 5-FU 4% Cream for the Treatment of Actinic Keratosis: A Delphi Consensus
Gabriella Brancaccio, Giulia Briatico, Zoé Apalla, et al.
Dermatology Practical & Conceptual (2025) Vol. 15, Iss. 2, pp. 5787-5787
Open Access
Gabriella Brancaccio, Giulia Briatico, Zoé Apalla, et al.
Dermatology Practical & Conceptual (2025) Vol. 15, Iss. 2, pp. 5787-5787
Open Access
Severity of Local Skin Reactions with 4% 5-Fluorouracil Plus Emollient versus 4% 5-Fluorouracil Alone in Patients with Actinic Keratosis: A Single-Blind Randomised Trial
Eggert Stockfleth, Thomas Jouary, Francesca Farnetani, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 4, pp. 1013-1027
Open Access | Times Cited: 6
Eggert Stockfleth, Thomas Jouary, Francesca Farnetani, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 4, pp. 1013-1027
Open Access | Times Cited: 6
Actinic Keratoses: A Prospective Pilot Study on a Novel Formulation of 4% 5-Fluorouracil Cream and a Review of Other Current Topical Treatment Options
Ludovica Toffoli, Caterina Dianzani, Serena Bonin, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 2956-2956
Open Access | Times Cited: 5
Ludovica Toffoli, Caterina Dianzani, Serena Bonin, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 2956-2956
Open Access | Times Cited: 5
Assessing outcomes of topical 5-fluorouracil as primary and adjuvant therapy for squamous cell carcinoma in-situ
Dawn Queen, Megan H. Trager, Weijia Fan, et al.
Archives of Dermatological Research (2024) Vol. 316, Iss. 6
Closed Access | Times Cited: 1
Dawn Queen, Megan H. Trager, Weijia Fan, et al.
Archives of Dermatological Research (2024) Vol. 316, Iss. 6
Closed Access | Times Cited: 1
Refusal of Retreatment With Topical 5-Fluorouracil Among Patients With Actinic Keratosis: Qualitative Analysis
Rohan Singh, Sarah McCain, Steven R. Feldman
JMIR Dermatology (2023) Vol. 6, pp. e39988-e39988
Open Access | Times Cited: 3
Rohan Singh, Sarah McCain, Steven R. Feldman
JMIR Dermatology (2023) Vol. 6, pp. e39988-e39988
Open Access | Times Cited: 3
Evaluating the Efficacy and Safety of 4% 5-Fluorouracil Cream in Patients with Actinic Keratosis: An Expert Opinion
Eggert Stockfleth, Markus V. Heppt, Nathalie Bégeault, et al.
Acta Dermato Venereologica (2023) Vol. 103, pp. adv11954-adv11954
Open Access | Times Cited: 3
Eggert Stockfleth, Markus V. Heppt, Nathalie Bégeault, et al.
Acta Dermato Venereologica (2023) Vol. 103, pp. adv11954-adv11954
Open Access | Times Cited: 3
Does early discontinuation of topical 4% 5‐fluorouracil affect lesion clearance for actinic keratosis? Results from a dose‐ranging study
Markus V. Heppt, Claas Ulrich
Journal of the European Academy of Dermatology and Venereology (2024)
Open Access
Markus V. Heppt, Claas Ulrich
Journal of the European Academy of Dermatology and Venereology (2024)
Open Access
Neues in der Diagnostik und Therapie der aktinischen Keratose
Markus V. Heppt
Deleted Journal (2024) Vol. 75, Iss. 10, pp. 815-822
Closed Access
Markus V. Heppt
Deleted Journal (2024) Vol. 75, Iss. 10, pp. 815-822
Closed Access
5-fluorouracil 5% cream for squamous cell carcinoma in situ: Factors impacting treatment response
Christine Lin, Nour Kibbi, Tarek Bandali, et al.
Journal of the American Academy of Dermatology (2024)
Closed Access
Christine Lin, Nour Kibbi, Tarek Bandali, et al.
Journal of the American Academy of Dermatology (2024)
Closed Access
Patients who refuse topical 5-fluoruoracil treatment: a qualitative analysis. (Preprint)
Rohan Singh, Sarah McCain, Ayman Grada, et al.
(2022)
Closed Access
Rohan Singh, Sarah McCain, Ayman Grada, et al.
(2022)
Closed Access
